Come up with a name for your new list and we'll add to it:
Skyhawk Therapeutics raised a round of funding on September 25, 2017. Investors include
Good Growth Capital.
Skyhawk Therapeutics, fka Rare Genetix, is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression.…